5 FDA decisions to watch in the fourth quarter
Novo Nordisk challenges CMS drug price negotiations, then signs on to the program
Biogen nabs FDA nod for biosimilar version of Roche's blockbuster Actemra
Nobel Prize goes to scientists who made mRNA COVID vaccines possible
*please scroll down for all the latest news*
